Real-World Efficacy of Bezlotoxumab for Prevention of Recurrent Clostridium Difficile Infection: A Retrospective Study of 46 Patients in Five University Hospitals in Finland

European Journal of Clinical Microbiology and Infectious Diseases - Germany
doi 10.1007/s10096-019-03630-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search